Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies

Completed

Conditions studied: Down Syndrome, Fetal Aneuploidy

In brief

Whole blood samples will be collected from high-risk pregnant women to validate the clinical performance of the SEQureDx Trisomy 21 Test.

Key facts

Study ID
NCT01555346
Run by
Sequenom, Inc.
People needed
3062
Starts
2012-03-01
Expected to finish
2015-12-01
Last updated by the study team
2016-04-20

Who can join

Age: 18 and older, up to 60. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.